Pegylated irinotecan (JK-1201I)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated irinotecan (JK-1201I), covering 2024-09-04 to 2024-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor [Phase 1]